In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...
It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol ...
Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...
Flow Space on MSN
When Lupus Symptoms Get Dismissed: The Real Barriers Keeping Women From Better Treatment
Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...
As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...
Study Finds on MSN
Viral protein found in cancer, lupus, ALS traced to infection from millions of years ago
We’re all mostly human. 8% of your genome comes from viruses. In A Nutshell Scientists captured the first detailed images of HERV-K, a viral protein found in cancer cells, lupus, and ALS patients HERV ...
The total market size of systemic lupus erythematosus is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research of therapies such as nipocalimab (Johnson & ...
Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
Flow Space on MSN
The silent burden of lupus flares: How to advocate for yourself when symptoms don't add up
Lupus is often marked by flares, which is when symptoms are usually more obvious.
Systemic Lupus Erythematosus is one of the most complex autoimmune diseases seen in modern medicine, affecting multiple organs and presenting differently from one patient to another. Often referred to ...
Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback